These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35038459)

  • 21. Recombinant human erythropoietin treatment of anemia in renal transplant patients.
    Lezaic V; Djukanovic L; Pavlovic-Kentera V
    Ren Fail; 1995 Nov; 17(6):705-14. PubMed ID: 8771243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF; Law CB; Ting SM; Li P; Lai KN
    Clin Nephrol; 1991 Nov; 36(5):246-51. PubMed ID: 1752075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of rHuEpo therapy in dialysis patients on endogenous erythropoietin synthesis after renal transplantation.
    Fernández Lucas M; Marcén R; Villafruela J; Teruel JL; Tato A; Rivera M; Ortuño J
    Nephron; 1996; 73(1):54-7. PubMed ID: 8742957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythropoietin for anaemia in haemodialysis patients: results of a maintenance study (the Canadian Erythropoietin Study Group).
    Muirhead N; Laupacis A; Wong C
    Nephrol Dial Transplant; 1992; 7(8):811-6. PubMed ID: 1325613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of thalassemia on the response to recombinant human erythropoietin in dialysis patients.
    Cheng IK; Lu HB; Wei DC; Cheng SW; Chan CY; Lee FC
    Am J Nephrol; 1993; 13(2):142-8. PubMed ID: 8342581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytoprotective effect of recombinant human erythropoietin produced in transgenic tobacco plants.
    Kittur FS; Bah M; Archer-Hartmann S; Hung CY; Azadi P; Ishihara M; Sane DC; Xie J
    PLoS One; 2013; 8(10):e76468. PubMed ID: 24124563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraperitoneal administration of recombinant human erythropoietin.
    Frenken LA; Struijk DG; Coppens PJ; Tiggeler RG; Krediet RT; Koene RA
    Perit Dial Int; 1992; 12(4):378-83. PubMed ID: 1420497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impacts of recombinant human erythropoietin treatment during predialysis periods on the progression of chronic kidney disease in a large-scale cohort study (Co-JET study).
    Akizawa T; Saito A; Gejyo F; Suzuki M; Nishizawa Y; Tomino Y; Tsubakihara Y; Akiba T; Hirakata H; Watanabe Y; Kawanishi H; Bessho M; Udagawa Y; Aoki K; Uemura Y; Ohashi Y;
    Ther Apher Dial; 2014 Apr; 18(2):140-8. PubMed ID: 24720404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response to erythropoietin in pediatric patients with chronic kidney disease: insights from an in vitro bioassay.
    Gavish R; Watad S; Ben-Califa N; Goldberg OJ; Haskin O; Davidovits M; Koren G; Falush Y; Neumann D; Krause I
    Pediatr Nephrol; 2018 Nov; 33(11):2123-2129. PubMed ID: 30030607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of Aspirin in normalization of recombinant human erythropoietin-mediated hyper-reactivity of platelets in rats.
    Soni HM; Vekaria AM; Rath AC; Belemkar S; Jain MR
    Indian J Pharmacol; 2014; 46(3):328-33. PubMed ID: 24987182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the erythropoietin receptor in Lung Cancer cells: erythropoietin exhibits angiogenic potential.
    Liu X; Tufman A; Behr J; Kiefl R; Goldmann T; Huber RM
    J Cancer; 2020; 11(20):6090-6100. PubMed ID: 32922549
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy of erythropoietin administration in the treatment of anemia immediately after renal transplantation.
    Van Biesen W; Vanholder R; Veys N; Verbeke F; Lameire N
    Transplantation; 2005 Feb; 79(3):367-8. PubMed ID: 15699772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
    Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
    J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is it time for a paradigm shift? Is erythropoietin deficiency still the main cause of renal anaemia?
    Eschbach JW; Varma A; Stivelman JC
    Nephrol Dial Transplant; 2002; 17 Suppl 5():2-7. PubMed ID: 12091599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modified recombinant human erythropoietin with potentially reduced immunogenicity.
    Susantad T; Fuangthong M; Tharakaraman K; Tit-Oon P; Ruchirawat M; Sasisekharan R
    Sci Rep; 2021 Jan; 11(1):1491. PubMed ID: 33452310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ACE inhibitors or angiotensin II receptor blockers in dialysed patients and erythropoietin resistance.
    Saudan P; Halabi G; Perneger T; Wasserfallen JB; Wauters JP; Martin PY;
    J Nephrol; 2006; 19(1):91-6. PubMed ID: 16523432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity.
    Soubasi V; Kremenopoulos G; Diamanti E; Tsantali C; Sarafidis K; Tsakiris D
    J Pediatr; 1995 Aug; 127(2):291-7. PubMed ID: 7636658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Does long-term erythropoietin therapy influence the prevalence of serum markers of hepatitis B and C in haemodialysed uraemic patients?].
    Mesjasz J; Wiecek A; Gonciarz Z; Mazur W; Kokot F
    Pol Merkur Lekarski; 2004 Apr; 16(94):362-7. PubMed ID: 15517934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for amelioration of endothelial cell dysfunction by erythropoietin therapy in predialysis patients.
    Kuriyama S; Hopp L; Yoshida H; Hikita M; Tomonari H; Hashimoto T; Sakai O
    Am J Hypertens; 1996 May; 9(5):426-31. PubMed ID: 8735172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enzymatic Synthesis and Characterization of Hydrophilic Sugar Based Polyesters and Their Modification with Stearic Acid.
    Bilal MH; Prehm M; Njau AE; Samiullah MH; Meister A; Kressler J
    Polymers (Basel); 2016 Mar; 8(3):. PubMed ID: 30979182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.